Statistics

Total Visits

Views
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial 47

Total Visits per Month

March 2019 April 2019 May 2019 June 2019 July 2019 August 2019 September 2019
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial 0 1 0 0 0 0 0

File Downloads

Views
PUB1369635822016216122428.pdf 27

Top Country Views

Views
China 10
United Kingdom 5
United States 2

Top City Views

Views
Shenzhen 8
Alexandria 5
Beijing 2
Wilmington 2